PACT

What PACT does

PACT is a Cambridge, UK-based biomaterials company founded in 2020 that develops sustainable alternatives to plastic textiles and conventional leather. Its core product, Oval, is a patented collagen-based material platform crafted from cosmetic-grade collagen transformed into collagen skins, enriched with natural ingredients and finished using time-honored techniques. The company describes its production process as using zero harsh chemicals and offering a low-carbon footprint by upcycling nutrient-rich collagen waste into premium material feedstock.

The company sells its Oval biomaterial on a B2B basis to enterprise customers across four verticals: fashion and apparel brands (its primary segment, targeting luxury Maisons), interior design and furniture, footwear, and automotive. PACT positions itself as a collaborative material-innovation partner rather than a commodity supplier, emphasizing bespoke technology, design co-development, and seamless integration into existing brand supply chains. Its go-to-market is enterprise field sales through direct partnership engagement, supplemented by LinkedIn and its website (pact.earth) for top-of-funnel awareness.

As of October 2025, PACT had raised over €17.2M in Series A funding co-led by Forbion and HV Capital, following a ~$12M round in September 2024 led by Hoxton Ventures. The company operates a pilot plant in Cambridge and is in pre- or very early commercial scaling, with no disclosed revenue. Its leadership team combines PhD-level materials science expertise with senior operations and product development leadership drawn from advanced materials industries, complemented by an advisory panel drawn heavily from luxury fashion houses (Hermès, Louis Vuitton, Bottega Veneta, LOEWE, Aesop) and sustainability leaders (former Patagonia CEO, ex-Kering/Pangaia).

Name

PACT

Legal name

PACT

Website

https://pact.earth

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

PACT is a Cambridge, UK biomaterials company (founded 2020) that produces Oval, a patented collagen-based sustainable material, and sells it B2B to enterprise brands in fashion, interiors, footwear, and automotive as a plastic and leather alternative.

Ownership category

akta.pro rank

Product category

Sustainable Biomaterials

NAICS

Other Leather and Allied Product Manufacturing (316990)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Bioplastics Compounding & Masterbatch (bio-based additives, colorants, fillers) (IMANANAB)

Keywords

• Collagen biomaterials
• Sustainable leather alternatives
• Bio-based textiles
• Natural material science
• Circular fashion materials

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Biomaterial Sales: PACT generates revenue through the sale of its Oval collagen-based biomaterial to brand partners. The material targets multiple industries including fashion, interiors, footwear, and automotive, positioning PACT as a B2B supplier of sustainable material alternatives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PACT designs and manufactures Oval, a patented collagen-based biomaterial produced from cosmetic-grade collagen that is transformed into collagen skins, enriched with all-natural ingredients, and finished using traditional techniques. The material is supplied to enterprise fashion, interiors, footwear, and automotive brands as a sustainable alternative to plastic textiles and conventional leather. Production runs out of PACT's Cambridge pilot plant, with additional biomaterials in the R&D pipeline.

Product overview

PACT is a biomaterials company that has developed a single core product platform called Oval, a collagen-based sustainable material designed to replace plastic in textiles and various applications. The company transforms cosmetic-grade collagen into innovative biomaterials using a patented process, creating a supple material for creative and industrial use. While Oval is the primary commercial product, PACT's R&D pipeline includes additional biomaterials in development for broader consumer industries.

Differentiator

Problem solved

Functional benefit

Brands

• Oval: Revolutionary collagen-based biomaterial platform designed to replace plastic in textiles, fashion, interiors, footwear, and automotive applications. Made from cosmetic-grade collagen transformed into collagen skins enriched with all-natural ingredients.

Products and services

• Oval Oval is a patented collagen-based biomaterial platform that serves as a sustainable alternative to plastic in textiles and other applications. It is crafted from cosmetic-grade collagen transformed into collagen skins, enriched with all-natural ingredients, and finished using traditional techniques, targeting enterprise Maison partners in fashion, interiors, footwear, and automotive sectors.

Quantifiable outcome

• Radically reduces environmental impact compared to plastic textiles

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Keel Labs: North American maker of seaweed-based fiber (Kelsun) for apparel. Adjacent emerging biomaterials competitor in sustainable next-gen textile fibers.
• VitroLabs: Cell-cultivated (lab-grown) leather startup targeting luxury fashion. Comparable emerging player in next-generation leather materials competing for the same Maison partnerships.
• Ecovative Design: Mycelium-based materials company with Forager leather alternative among other bio-fabricated products. Comparable emerging player in next-gen materials with adjacent technology base to PACT.
• Natural Fiber Welding (CLIR Technologies): US-based materials company developing plant-protein-based leather and textile alternatives. Comparable emerging biomaterials peer targeting fashion and footwear applications.
• Algiknit: Developer of seaweed-based yarns and textiles for fashion. Adjacent emerging biomaterials peer in sustainable next-generation fiber production for apparel and footwear.

Direct peers

• MycoWorks: Producer of Reishi, a mycelium-based luxury leather alternative with major fashion-house partnerships (e.g., Hermès, Ligne Roset). Direct competitor for the same luxury Maison customer base PACT targets.
• Bolt Threads: US-based bio-fabricated materials company producing protein-based and mycelium textiles and leather alternatives. Direct competitor to PACT in next-gen fashion and footwear materials for luxury brands.
• Ananas Anam: Maker of Piñatex, a pineapple-leaf-fiber leather alternative sold into fashion and footwear. Comparable plant-based leather-alternative competitor with established brand partnerships.
• Spiber: Japanese biotech company producing Brewed Protein, a fermentation-derived protein fiber used as a textile and leather alternative. Competes with PACT in protein-based biomaterials for apparel and automotive.
• Modern Meadow: Bio-fabricated leather and materials company focused on fashion and automotive applications. Directly comparable to PACT's collagen-based Oval targeting luxury and automotive interiors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pactearth

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PACT